Ebola
How small clinical trial sample sizes can offer important findings
Scientists have been racing to develop COVID-19 vaccines that could reach millions, yet many of the studies have surprisingly small sample sizes drawn from the clinical trials. Does that matter?
From biodefence to the DRC: How the Ebola vaccine became one of the fastest vaccines to license in history
COVID-19 vaccines are set to become the quickest vaccines in history to go from initial trials to rollout, but what lessons can we learn from its speedy predecessor: the Ebola vaccine?
New vaccines to meet emerging needs
Here’s how Gavi helps lower-income countries get the new vaccines and products they need to address urgent threats to public health – from cholera and COVID-19, to Ebola and pneumonia.
Leaders in the fight against infectious diseases
Snapshots from DRC, India and Zambia illustrate country ownership and progress in the fights against Ebola, polio and HPV.
How creative communication strategies are helping fight COVID-19 misinformation in DRC
The misinformation surrounding COVID-19 in the Democratic Repubic of the Congo isn’t new – public health officials have seen rumours and myths circulate with Ebola. Here’s how they are tackling them.
The vaccines success story gives us hope for the future
As the world waits for a vaccine to defeat the COVID-19 pandemic, we look back to all that vaccines have achieved for humanity.
